Fanconi Anemia, Complementation Group L (FANCL) Peptide
FANCL
Reactivity: Mammalian
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN936892
Quick Overview for Fanconi Anemia, Complementation Group L (FANCL) Peptide (ABIN936892)
Target
FANCL
(Fanconi Anemia, Complementation Group L (FANCL))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Peptide Type
- Synthetic
-
Sequence
- ASGREHLITL KLKAKYPAES PDYFVDFPVP FCASWTPQVN SPQSSLISIY
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of FANCL antibody,
Alternative Names: FANCL control peptide, FANCL antibody Blocking Peptide, Anti-FANCL Blocking Peptide, Fanconi Anemia Complementation Group L Blocking Peptide, FAAP43 Blocking Peptide, FLJ10335 Blocking Peptide, PHF9 Blocking Peptide, POG Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- FANCL (Fanconi Anemia, Complementation Group L (FANCL))
-
Background
- The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ, FANCL, FANCM and FANCN. The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair.
-
Molecular Weight
- 42 kDa
Target
-
You are here:
